Market: NMS |
Currency:
Address:
๐ ETS Historical Chart
๐ Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
๐ฐ Dividend History
No dividend history available.
๐
Earnings & EPS History for ETS
No earnings history available for this symbol.
๐ฐ Related News & Research
-
UFP Industries Acquires Oldcastle APGโs MoistureShield Assets to Double Deckorators Composite Decking Capacity by 2027
April 7, 2026
UFP Industries Expands Deckoratorsยฎ Composite Decking Capaci...
-
FrontView REIT Acquires $34 Million in Properties and Targets $100 Million Net Investment for 2026
April 7, 2026
FrontView REIT Q1 2026 Investment Update: Key Financial High...
-
Mach Natural Resources LP Acquires IKAV and Sabinal Oil & Gas Assets: Pro Forma Financials and Reserve Highlights for 2025
April 7, 2026
Mach Natural Resources LP Announces Major Acquisitions, Expa...
-
Yangzijiang Shipbuilding (SGD) Stock Analysis: Bullish Technical Outlook & Price Targets for 2026
April 7, 2026
Broker Name: Lim & Tan Securities Date of Report: 07 April 2...
-
Global Markets Update April 2026: US, Asia, and Singapore Stocks Rise Amid Middle East Tensions and Hospitality Sector Outlook 12
April 7, 2026
Report Summary Key Actionable BUY Calls: ...
-
ProCap Financial Acquires CFO Silvia, Bringing $30 Billion in Assets to AI-Driven Finance Platform
April 6, 2026
ProCap Financial Completes Acquisition of CFO Silvia - Inves...
-
Howmet Aerospace Inc. Files Form 8-K for Acquisition or Disposition of Assets on April 6, 2026
April 6, 2026
Howmet Aerospace Inc. Files Form 8-K: Completion of Acquisit...
-
Profusa Inc. Signs $30 Million Non-Binding LOI to Acquire PanOmics Assets from Bio Insights LLC
April 6, 2026
Profusa, Inc. Announces Non-Binding Letter of Intent to Acqu...
-
Encore Medical IPO: Innovative PFO Closure Device Targets $1.5B Stroke & $100B Migraine Markets | Investment Opportunity & Clinical Trials Overview 2491018
April 5, 2026
Encore Medical, Inc. IPO: Investor-Grade Analysis, Financial...
-
Forum Markets, Inc. Files 8-K Announcing Performance and Restricted Stock Unit Award Agreements โ April 2026
April 4, 2026
Forum Markets, Inc. Files 8-K: New Equity Incentive Awards a...
๐ View more Reports